Extensive lichenoid drug eruption due to glyburide: a case report and review of the literature.

Extensive lichenoid drug eruption due to glyburide: a case report and review of the literature.

Cutis (2005-09-08)

Gary N Fox, Colleen C Harrell, Darius R Mehregan

ABSTRACT

Lichenoid reactions to sulfonylurea drugs have been reported, albeit infrequently. To our knowledge, this is the first case of a generalized lichenoid dermatitis likely induced by the third-generation sulfonylurea hypoglycemic drug glyburide.

MATERIALS

Product Number

Brand

Product Description

G2539

Sigma-Aldrich

Glyburide, meets USP testing specifications

G0639

Sigma-Aldrich

Glybenclamide, ≥99% (HPLC)

G0325000

Glybenclamide, European Pharmacopoeia (EP) Reference Standard

Y0001511

Glibenclamide for peak identification, European Pharmacopoeia (EP) Reference Standard

PHR1287

Supelco

Glyburide (Glibenclamide), Pharmaceutical Secondary Standard; Certified Reference Material